Teva Pharmaceutical reported 971M in EBIT for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aspen Pharmacare APN:SJ 3.9B 313M
Cipla CIPLA:IN 9.84B 103.6M
Dr.Reddys Laboratories DRRD:IN 9.26B 1.4B
Jiangsu Hengrui Me. 600276:CH 1.68B 320.6M
Richter Gedeon RICHT:HB 46.29B 14.48B
Sun Pharmaceuticals SUNP:IN 20.63B 1.13B
Teva Pharmaceutical TEVA:IT 971M 165M